His primary areas of study are Genetic enhancement, Adeno-associated virus, Vector, Virology and Molecular biology. His studies deal with areas such as Viral vector, Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator and Pathology as well as Genetic enhancement. His Adeno-associated virus study contributes to a more complete understanding of Recombinant DNA.
The various areas that he examines in his Vector study include Virus and Immunology. The Virology study combines topics in areas such as Context, Cell culture, Adenoviridae and DNA virus. His Molecular biology research is multidisciplinary, incorporating elements of Transgene, Gene expression, Gene, DNA and Expression vector.
Genetic enhancement, Adeno-associated virus, Virology, Recombinant DNA and Immunology are his primary areas of study. The study incorporates disciplines such as Transgene, Bioinformatics, Vector, Virus and Transduction in addition to Genetic enhancement. His Adeno-associated virus study combines topics in areas such as Gene delivery, Recombinant virus, Gene expression, Molecular biology and In vivo.
His Virology research integrates issues from Adenoviridae and Viral vector. The study incorporates disciplines such as Titer and Alpha in addition to Recombinant DNA. Many of his studies on Immunology apply to Cystic fibrosis as well.
His scientific interests lie mostly in Genetic enhancement, Genome editing, Virology, MEDLINE and Adeno-associated virus. Terence R. Flotte has researched Genetic enhancement in several fields, including Harassment, Pediatrics and Bioinformatics. The Virology study combines topics in areas such as Recombinant DNA and DNA vaccination.
His Recombinant DNA research includes elements of Newborn screening, Virus, Plasmid and Regulatory Pathway. His work carried out in the field of Adeno-associated virus brings together such families of science as Severe toxicity, Serotype, Immune system, Immunity and Transduction. His biological study spans a wide range of topics, including Molecular biology and Therapy Trial.
Terence R. Flotte mostly deals with Genetic enhancement, Adeno-associated virus, Genome editing, Virus and Virology. His Genetic enhancement research includes themes of Transgene and Bioinformatics. His study ties his expertise on Immunity together with the subject of Adeno-associated virus.
The various areas that Terence R. Flotte examines in his Genome editing study include Computational biology and Cas9. His research investigates the link between Virus and topics such as Recombinant DNA that cross with problems in Muscle tissue. His studies deal with areas such as Severe toxicity and Transduction as well as Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth;Tomas S. Aleman;Shalesh Kaushal;Artur V. Cideciyan.
Human Gene Therapy (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan;Tomas S. Aleman;Sanford L. Boye;Sharon B. Schwartz.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
Terence R. Flotte;Sandra A. Afione;Carol Conrad;Sharon A. McGrath.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Adeno-associated virus vectors for gene therapy
T R Flotte;B J Carter.
Gene Therapy (1995)
Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR
Marie Egan;Terence Flotte;Terence Flotte;Sandra Afione;Rikki Solow.
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
Pei Wu;Wu Xiao;Thomas Conlon;Jeffrey Hughes.
Journal of Virology (2000)
Adeno-associated virus with inverted terminal repeat sequences as promoter
Carter Barrie J;Flotte Terrence;Afione Sandra;Solow Rikki.
Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter
Terence R. Flotte;Sandra A. Afione;Rikki Solow;Mitchell L. Drumm.
Journal of Biological Chemistry (1993)
Clinical gene therapy using recombinant adeno-associated virus vectors
Christian Mueller;Terence R. Flotte.
Gene Therapy (2008)
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
Sihong Song;Michael Morgan;Tamir Ellis;Amy Poirier.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Human Gene Therapy
(Impact Factor: 4.793)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: